These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4128244)

  • 21. Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.
    Banovac K; Zakarija M; McKenzie JM; Witte A; Sekso M
    J Clin Endocrinol Metab; 1981 Sep; 53(3):651-3. PubMed ID: 6790561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.
    Pinchera A; Liberti P; De Santis R; Grasso L; Martino E; Baschieri L
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1758-60. PubMed ID: 6072765
    [No Abstract]   [Full Text] [Related]  

  • 23. The long-acting thyroid stimulator.
    Munro DS
    J R Coll Physicians Lond; 1972 Apr; 6(3):309-15. PubMed ID: 5066947
    [No Abstract]   [Full Text] [Related]  

  • 24. What is the antibody specificity of LATS?
    Fagraeus A; Jonsson J; el-Kabir DJ
    J Clin Endocrinol Metab; 1970 Oct; 31(4):445-7. PubMed ID: 4916544
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-acting thyroid stimulator in Graves' disease.
    Sellers EA; Awad AG; Schönbaum E
    Lancet; 1970 Aug; 2(7668):335-8. PubMed ID: 4194442
    [No Abstract]   [Full Text] [Related]  

  • 26. Hereditary aspects of Graves' disease in infancy and childhood.
    Hollingsworth DR; Mabry CC; Eckerd JM
    J Pediatr; 1972 Sep; 81(3):446-59. PubMed ID: 5068321
    [No Abstract]   [Full Text] [Related]  

  • 27. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
    McKenzie JM; Zakarija M
    J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Simultaneous study of LATS and antimicrosomial antibodies in untreated Basedow's disease].
    Orgiazzi J; Pousset G; Durand H
    Presse Med (1893); 1971 May; 79(25):1167-8. PubMed ID: 4933634
    [No Abstract]   [Full Text] [Related]  

  • 30. Thyrotrophin binding inhibiting immunoglobulins in Graves' disease before, during and after antithyroid therapy, and its relation to long-acting thyroid stimulator.
    Docter R; Bos G; Visser TJ; Hennemann G
    Clin Endocrinol (Oxf); 1980 Feb; 12(2):143-53. PubMed ID: 6105023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid-stimulating immunoglobulins in ophthalmic Graves' disease.
    Teng CS; Smith BR; Clayton B; Evered DC; Clark F; Hall R
    Clin Endocrinol (Oxf); 1977 Mar; 6(3):207-11. PubMed ID: 404101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.
    Ginsberg J; von Westarp C
    CMAJ; 1986 May; 134(10):1141-7. PubMed ID: 2421862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of Graves' disease and endocrine exophthalmos.
    Anderson DR
    Am J Ophthalmol; 1969 Jul; 68(1):46-57. PubMed ID: 4895778
    [No Abstract]   [Full Text] [Related]  

  • 34. Thyroid physiology and functional tests.
    Zellmann HE
    Major Probl Clin Surg; 1974; 15(0):55-70. PubMed ID: 4138680
    [No Abstract]   [Full Text] [Related]  

  • 35. Familial hyperthyroidism including two siblings with neonatal Graves' disease.
    Wilroy RS; Etteldorf JN
    J Pediatr; 1971 Apr; 78(4):625-32. PubMed ID: 5107851
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-acting thyroid stimulator (LATS) and long acting thyroid stimulator protector (LATS-P) in untreated thyrotoxicosis.
    Hardisty CA; Hanford L; Humphries H; Munro DS
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):631-9. PubMed ID: 6895353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-acting thyroid stimulator and related factors.
    Kendall-Taylor P; Dirmikis SM; Munro DS
    Proc R Soc Med; 1975 Apr; 68(4):252-3. PubMed ID: 1242809
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease.
    Zakarija M; McKenzie JM; Munro DS
    J Clin Invest; 1983 Oct; 72(4):1352-6. PubMed ID: 6138363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic aspects of Graves' and Hashimoto's diseases.
    Kidd A; Okita N; Row VV; Volpé R
    Metabolism; 1980 Jan; 29(1):80-99. PubMed ID: 6986013
    [No Abstract]   [Full Text] [Related]  

  • 40. [Biological investigation in hyperthyroidism].
    Guinet P
    Cah Med; 1972 Dec; 13(17):1235-42. PubMed ID: 4121374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.